According to NICE ( Intrapartum care for healthy
women and babies )

• Check blood pressure every 5 minutes for 15 minutes during
  establishment or after further boluses
• Check sensory block hourly
•  Continuous electronic fetal monitoring for 30 minutes during
  establishment or after boluses of 10 ml or more
• Intravenous access should be established prior to commencing regional analgesia.
• Do not administer routine preloading and maintenance fluid

Checking the environment is THE FIRST STEP. Who knows the patient has been electrocuted from a faulty electric wire ! Touching her without assessing the environment can harm the healthcare provider.

Women can be reassured that long-term survival after breast cancer is not adversely
affected by pregnancy.

In clinically suspected DVT or PE, treatment with low-molecular-weight heparin (LMWH) should be commenced immediately until the diagnosis is excluded by objective testing, unless treatment is strongly contraindicated.

Compression duplex ultrasound should be undertaken where there is clinical suspicion of DVT.
If ultrasound is negative and there is a low level of clinical suspicion, anticoagulant treatment can be discontinued.

If ultrasound is negative and a high level of clinical suspicion exists, anticoagulant
treatment should be discontinued but the ultrasound should be repeated on days 3 and 7.

Intravenous unfractionated heparin is the preferred, initial treatment in massive PE with cardiovascular compromise.

Undertake a urine dipstick test in all women presenting with urinary
incontinence to detect the presence of blood, glucose, protein, leucocytes and nitrites in the urine.

Codeine is converted to active metabolites, mainly morphine. The ultrarapid metaboliser phenotype is due to duplications of the CYP2D6 gene, and prevalence varies by ethnic origin.

Ultrarapid metabolisers who take codeine can have up to 50% higher plasma concentrations
of its active metabolite morphine than extensive metabolisers, with the consequence that there is a risk of serious toxicity even at therapeutic doses of codeine in such individuals.